​    January 25, 2016.  Applied Molecular  

     Transport to participate on expert panel at    
     ADVANCES IN BIOLOGICS DEVELOPMENT
     AND DELIVERY symposium in San 
     Francisco at UCSF Genentech Hall on

     March 24, 2016 

Our microbe-inspired protein scaffolding, cellular translocation and targeting platform is enabling next-generation biopharmaceuticals with superior pharmacological properties and enhanced safety profiles.

Copyright © APPLIED MOLECULAR TRANSPORT, LLC 2016. All rights reserved.

Our microbe-inspired protein scaffolding platform is enabling the rapid engineering and validation of next-generation biopharmaceuticals with superior pharmacological properties, without the need for injection.

​​​Applied Molecular Transport is developing a transformative pipeline of oral and targeted biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core therapeutic areas of focus are Autoimmune Diseases & Inflammation, and Metabolic Diseases & Diabetes.

​​Applied Molecular Transport is developing a transformative pipeline of oral biological therapeutics that promise to redefine the future of biopharmaceuticals.


The company's core focus is in the areas of immune-mediated inflammation and metabolic diseases.